Reassessment of global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine

被引：0
|
作者：
Tamura, RN [1 ]
Lu, YL [1 ]
机构：
[1] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA
来源：
JOURNAL OF PSYCHIATRIC RESEARCH | 2003年 / 37卷 / 02期
关键词：
D O I：
10.1016/S0022-3956(02)00090-0
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：175 / 176
页数：2
相关论文
共 50 条
  • [1] Global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine
    Entsuah, R
    Gorman, JM
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2002, 36 (03) : 111 - 118
  • [2] Reassessment of global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine - Response to Roy N. Tamura and Yiti Lu letter to the editor
    Entsuah, R
    Lu, YL
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2003, 37 (02) : 176 - 177
  • [3] A benefit-risk analysis of once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression
    Entsuah, R
    Chitra, R
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (04) : 671 - 676
  • [4] Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report
    Warner, Margaret R.
    Wolka, Anne M.
    Noel, Rebecca A.
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (03) : 342 - 346
  • [5] Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report
    Margaret R. Warner
    Anne M. Wolka
    Rebecca A. Noel
    [J]. Therapeutic Innovation & Regulatory Science, 2016, 50 : 342 - 346
  • [6] Benefit-risk assessment of vaccines
    Kochhar, Sonali
    Izurieta, Hector S.
    Chandler, Rebecca E.
    Hacker, Adam
    Chen, Robert T.
    Levitan, Bennett
    [J]. VACCINE, 2024, 42 (04) : 969 - 971
  • [7] Estimand in benefit-risk assessment
    Ren, Xinru
    Chen, X. Gregory
    Seifu, Yodit
    Wang, William
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2023, 33 (04) : 452 - 465
  • [8] BENEFIT-RISK ASSESSMENT TODAY
    HALL, RE
    [J]. JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 1978, 55 (01) : 193 - 197
  • [9] Benefit-risk assessment of acne therapies
    Seukeran, DC
    Eady, EA
    Cunliffe, WJ
    [J]. LANCET, 1997, 349 (9060): : 1251 - 1252
  • [10] Patient Global Impression of Benefit-Risk (PGI-BR): Incorporating Patients' Views of Clinical Benefit-Risk into Assessment of New Medicines
    Eek, Daniel
    Halling, Katarina
    Flood, Emuella
    Blowfield, Matthew
    Meyers, Oren
    Venerus, Meredith
    Paty, Jean
    Hermann, Richard
    [J]. DRUG SAFETY, 2021, 44 (10) : 1059 - 1072
12345